Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Orteronel

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Orteronel?

Orteronel is an investigational drug.

There have been 17 clinical trials for Orteronel. The most recent clinical trial was a Phase 3 trial, which was initiated on November 15^th 2010.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Millennium Pharmaceuticals, Inc., National Cancer Institute (NCI), and Swiss Group for Clinical Cancer Research.

Summary for Orteronel

US Patents	0
International Patents	0
US Patent Applications	304
WIPO Patent Applications	215
Japanese Patent Applications	69
Clinical Trial Progress	Phase 3 (2010-11-15)
Vendors	42

Recent Clinical Trials for Orteronel

Title	Sponsor	Phase
AR-inhibitor Bicalutamide in Treating Patients With TNBC	Jiangsu Province Hospital of Traditional Chinese Medicine	Phase 2
AR-inhibitor Bicalutamide in Treating Patients With TNBC	Nanning Second People's Hospital	Phase 2
AR-inhibitor Bicalutamide in Treating Patients With TNBC	The First People's Hospital of Lianyungang	Phase 2

See all Orteronel clinical trials

Clinical Trial Summary for Orteronel

Top disease conditions for Orteronel

Top clinical trial sponsors for Orteronel

See all Orteronel clinical trials

US Patents for Orteronel

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Johnson and Johnson

Dow

Harvard Business School

McKinsey

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.